MedTrace Logo

Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology

NCT07312058 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2026-01-16

No results posted yet for this study

Summary

Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity.

Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment.

However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission.

This project aims to better understand the effectiveness, utilization, and psychological impacts of these strategies.

This work is part of an effort to understand and evaluate fertility preservation practices implemented for women of reproductive age undergoing cancer treatment at the Amiens-Picardie University Hospital (CHU).

Its objective is to document patient pathways, clinical decisions, techniques employed, and reproductive outcomes observed after remission, in order to identify potential areas for improvement in the support and follow-up of these patients, thereby enhancing the overall quality and coordination of care.

This work is conducted alongside the development of a fertility observatory at the Department of Medicine and Reproductive Biology, CHU Amiens-Picardie.

Conditions

  • Fertility Preservation
  • Cancer Remission
  • Reproductive Outcomes
  • Reproductive Health
  • Oncology
  • Fertility Counseling
  • Assisted Reproductive Technology
  • Psychological Impact
  • Fertility Observatory
  • Patient Follow-up
  • Female Cancer Survivors
  • Fertility Preservation Techniques
  • Live Birth Rate

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
47 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-17
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07312058 on ClinicalTrials.gov